Clin2
NCT06650163Possibly a fitRecruiting

New imaging test for brain tumor surgery planning

GliomaMalignant Brain NeoplasmMeningiomaMetastatic Malignant Neoplasm in the Brain

Part of Brain & nervous system, Cancer clinical trials.

This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been diagnosed with a brain tumor (including metastatic tumors, gliomas, or meningiomas)
  • You are already scheduled to have surgery to remove the tumor
  • You are able to have an MRI and a PET/CT scan
  • Your kidney and liver function are within certain safe ranges

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03649880Recruiting· Phase 2
Testing a special PET scan for brain tumor activity

This trial studies whether a brain PET scan using a medicine called FMISO can help show how active certain brain tumors are. It mainly aims to see if the scan is practical and useful in planning care for people with suspected or known brain tumors.

Portland, Oregon
NCT05386043Recruiting
Study brain tumor testing with MRI and extra tissue samples

This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.

Indianapolis, Indiana
NCT03739411Recruiting· Phase 1
MRI scan with a special agent to assess brain tumors

This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.

San Francisco, California
NCT06667726Recruiting· Phase 2
New PET scan for better brain tumor care

This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.

Rochester, Minnesota
NCT05263466Not yet recruiting
Testing a radioactive PSMA scan for brain tumor surgery planning

This study tests whether a special radioactive scan that targets PSMA can help identify a high-grade brain tumor in people who are about to have surgery. It may help doctors better target treatment by confirming the tumor’s PSMA features using a radiolabeled imaging approach.

London
NCT07567196Recruiting
PET imaging to guide surgery for aggressive brain tumors

This trial tests whether using a special PET scan (a type of imaging that shows tumor activity) during brain tumor surgery helps doctors remove more of the tumor safely. You would have a high-grade glioma (an aggressive brain cancer) and be scheduled for surgery.

Torino, Turin

Hear when a new Glioma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.